Antimicrobial Efficacy of Cloxacillin-Loaded Chitosan Nanoparticles Against Staphylococcus aureus Biofilms in Subclinical Mastitis
Current Microbiology · 2025
DOI: 10.1007/s00284-024-04030-y ↗Kurz gefasst
Fachartikel in der Zeitschrift Current Microbiology, 2025. Verfasst von Mohammadsaeed Eskandari und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, Karaj Branch, Islamic Azad University, Karaj, Iran. Hauptthemen laut MEDLINE: Biofilms, Chitosan, Cloxacillin, Staphylococcus aureus. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 56 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology, Karaj Branch, Islamic Azad University, Karaj, Iran.
- Department of Pharmacology, Karaj Branch, Islamic Azad University, Karaj, Iran. zohreh.abdolmaleki@kiau.ac.ir.
- Department of Microbiology, Karaj Branch, Islamic Azad University, Karaj, Iran.
- Department of Clinical Sciences, Science and Research Branch, Islamic Azad University, Tehran, Iran.
ORCID-Profile: Zohreh Abdolmaleki
Zitieren
APA
Eskandari, M., Abdolmaleki, Z., Moosakhani, F., & Eslampour, M. A. (2025). Antimicrobial Efficacy of Cloxacillin-Loaded Chitosan Nanoparticles Against Staphylococcus aureus Biofilms in Subclinical Mastitis. Current Microbiology. https://doi.org/10.1007/s00284-024-04030-y
Vancouver
Eskandari M, Abdolmaleki Z, Moosakhani F, Eslampour MA. Antimicrobial Efficacy of Cloxacillin-Loaded Chitosan Nanoparticles Against Staphylococcus aureus Biofilms in Subclinical Mastitis. Current Microbiology. 2025. doi:10.1007/s00284-024-04030-y
BibTeX
@article{Eskandari2025,
author = {Eskandari, Mohammadsaeed and Abdolmaleki, Zohreh and Moosakhani, Farhad and Eslampour, Mohammad Amin},
title = {Antimicrobial Efficacy of Cloxacillin-Loaded Chitosan Nanoparticles Against Staphylococcus aureus Biofilms in Subclinical Mastitis},
journal = {Current Microbiology},
year = {2025},
doi = {10.1007/s00284-024-04030-y}
}
EUVIMED